Scarica l'app Stockscreener
1.75
0.00%
0.00
Dopo l'orario di chiusura:
1.71
-0.04
-2.29%
Precedente Chiudi:
$1.75
Aprire:
$1.72
Volume 24 ore:
4.21M
Relative Volume:
0.67
Capitalizzazione di mercato:
$210.25M
Reddito:
-
Utile/perdita netta:
$-225.14M
Rapporto P/E:
-0.8929
EPS:
-1.96
Flusso di cassa netto:
$-192.27M
1 W Prestazione:
-7.41%
1M Prestazione:
+38.89%
6M Prestazione:
+271.31%
1 anno Prestazione:
+77.54%
Intervallo 1D:
$1.675
$1.8094
Intervallo di 1 settimana:
$1.56
$2.01
Portata 52W:
$0.3546
$2.74
Invivyd Inc Stock (IVVD) Company Profile
Nome
Invivyd Inc
Settore
Industria
Telefono
(781) 819-0080
Indirizzo
1601 TRAPELO ROAD, WALTHAM
Confronta IVVD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IVVD
Invivyd Inc
|
1.75 | 349.49M | 0 | -225.14M | -192.27M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-04-05 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2024-03-26 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-19 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2023-05-01 | Iniziato | H.C. Wainwright | Buy |
Invivyd Inc Borsa (IVVD) Ultime notizie
Using data filters to optimize entry into Invivyd Inc.Portfolio Gains Summary & Free Expert Verified Stock Movement Alerts - newser.com
Real time pattern detection on Invivyd Inc. stockJuly 2025 Weekly Recap & Community Supported Trade Ideas - newser.com
Can a trend reversal in Invivyd Inc. lead to recovery2025 Price Action Summary & Breakout Confirmation Alerts - newser.com
Village Farms International Leads with 499.47% Return in Recent Performance Surge - Markets Mojo
Village Farms International Leads with 589.38% Return in Recent Performance Surge - Markets Mojo
How Invivyd Inc. stock performs in interest rate cyclesTrade Analysis Summary & Safe Entry Trade Reports - newser.com
Invivyd, Inc.'s (NASDAQ:IVVD) Price Is Right But Growth Is Lacking After Shares Rocket 31% - simplywall.st
What’s the recovery path for long term holders of Invivyd Inc.Quarterly Trade Review & AI Forecast for Swing Trade Picks - newser.com
Candlestick signals on Invivyd Inc. stock todayDollar Strength & Safe Investment Capital Preservation Plans - newser.com
Using Python tools to backtest Invivyd Inc. strategiesWeekly Profit Report & Technical Buy Zone Confirmations - newser.com
How to forecast Invivyd Inc. trends using time seriesJuly 2025 Update & AI Forecasted Entry/Exit Points - newser.com
Will Invivyd Inc. stock gain from strong economyPortfolio Risk Summary & Growth Focused Stock Reports - newser.com
What Fibonacci levels say about Invivyd Inc. reboundWeekly Gains Report & Free Fast Gain Swing Trade Alerts - newser.com
Is Invivyd Inc. stock in correction or buying zoneAnalyst Downgrade & Entry Point Confirmation Signals - newser.com
How to use Fibonacci retracement on Invivyd Inc.Market Growth Review & Free Community Consensus Stock Picks - newser.com
Cantor Fitzgerald Estimates Invivyd FY2025 Earnings - MarketBeat
Detecting support and resistance levels for Invivyd Inc.Quarterly Portfolio Review & Reliable Volume Spike Trade Alerts - newser.com
How supply chain issues affect Invivyd Inc. stockInsider Buying & Accurate Entry/Exit Alerts - newser.com
Ranking Invivyd Inc. among high performing stocks via toolsEarnings Risk Summary & Weekly Setup with High ROI Potential - newser.com
A Look at Invivyd’s (IVVD) Valuation Following FDA Clearance for Late-Stage COVID-19 Antibody Trial - simplywall.st
What candlestick patterns are forming on Invivyd Inc.July 2025 Momentum & Short-Term High Return Strategies - newser.com
Invivyd (IVVD) Is Up 34.4% After FDA Clears Late-Stage COVID Antibody Program—What’s Changed - Yahoo Finance
Invivyd (NASDAQ:IVVD) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
When is the best time to exit Invivyd Inc.Weekly Profit Analysis & Free Weekly Chart Analysis and Trade Guides - newser.com
Can Invivyd Inc. rally from current levelsPortfolio Gains Summary & Expert Approved Momentum Ideas - newser.com
Multi asset correlation models including Invivyd Inc.2025 Macro Impact & Weekly Watchlist for Consistent Profits - newser.com
Are Investors Undervaluing Invivyd, Inc. (NASDAQ:IVVD) By 31%? - 富途牛牛
Invivyd (IVVD) Is Up 26.8% After FDA Clears Phase 3 Trials for COVID Antibody Candidate - simplywall.st
Invivyd (IVVD): Assessing Valuation After FDA Clears Phase 3 COVID-19 Antibody Trial - Yahoo Finance
D. Boral Capital Maintains Invivyd (IVVD) Buy Recommendation - Nasdaq
Invivyd receives FDA clearance for COVID antibody prevention trials By Investing.com - Investing.com Nigeria
D. Boral Capital Increases Invivyd (NASDAQ:IVVD) Price Target to $2.00 - MarketBeat
Invivyd, Inc. Announces U.S. Food and Drug Administration Clearance of Investigational New Drug Application and Provide Feedback to Advance the Company's Revolation Clinical Program - MarketScreener
New Haven biotech advances vaccine-alternative to prevent COVID - Hartford Business Journal
Invivyd stock soars after FDA clears IND for COVID antibody candidate - Investing.com
Cantor Fitzgerald Initiates Invivyd at Overweight With $10 Price Target - MarketScreener
This Commerce Bancshares Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Invivyd Shares Climb After FDA Advances Its Covid-Preventing Drug - MarketScreener
Invivyd, Inc. (NASDAQ:IVVD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Invivyd (NASDAQ:IVVD) Now Covered by Cantor Fitzgerald - MarketBeat
Invivyd announces IND clearance, alignment with FDA on VYD2311 program - TipRanks
Invivyd’s VYD2311 Receives FDA Clearance for Trials - TipRanks
Invivyd receives FDA clearance for COVID antibody prevention trials - Investing.com
Invivyd gets FDA nod to start key trial of COVID-blocking antibody VYD2311 - MarketScreener
Invivyd Inc Azioni (IVVD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Invivyd Inc Azioni (IVVD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lee Timothy Edward | Chief Commercial Officer |
Aug 18 '25 |
Sale |
0.65 |
20,013 |
13,012 |
88,987 |
| Duke William E. | Chief Financial Officer |
Aug 19 '25 |
Sale |
0.57 |
29,643 |
16,796 |
49,344 |
| Duke William E. | Chief Financial Officer |
Aug 18 '25 |
Sale |
0.65 |
20,013 |
13,012 |
78,987 |
| Green Julie | Chief Human Resources Officer |
Aug 19 '25 |
Sale |
0.57 |
29,643 |
16,796 |
49,344 |
| Green Julie | Chief Human Resources Officer |
Aug 18 '25 |
Sale |
0.65 |
20,013 |
13,012 |
78,987 |
| Andersen Jill | Chief Legal Officer, Secretary |
Aug 19 '25 |
Sale |
0.57 |
49,402 |
27,991 |
84,446 |
| Andersen Jill | Chief Legal Officer, Secretary |
Aug 18 '25 |
Sale |
0.65 |
33,352 |
21,685 |
133,848 |
| Allen Robert D. III | Chief Scientific Officer |
Aug 19 '25 |
Sale |
0.57 |
27,420 |
15,536 |
53,068 |
| Allen Robert D. III | Chief Scientific Officer |
Aug 18 '25 |
Sale |
0.65 |
18,512 |
12,037 |
80,488 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):